Live Locally, Grow Globally

What's NEW

Science, Technology 
Seminars & Symposiums

Japan Combinatorial Chemistry Focus Group--Seminar

2009-6-2 (Tue) -

Seminar Series

Japan Combinatorial Chemistry Focus Group

Overcoming health problems related to one's life style, chronic conditions such as allergies, and serious diseases such as cancer, cardiac diseases or cerebropathy is an important issue for modern society.

With the globalization of the world, the rapid spread of new or reemerging infectious diseases such as new types of influenza or West Nile fever, the increase of tropical disease such as malaria, cholera, dengue fever, and others in connection with global warming are threatening the human race. 

In order to solve such issues facing the human race in the 21st century, the acceleration of research in drug development is a crucial issue. Developing new medicines employing new concepts or technology such as combinatorial chemistry or genome medicine development is not easy. In order to cope with this situation, cooperation between industry, government and academia, bridging the individual fields of pharmacology, chemistry, biology and medicine is needed. 

In the NIH Roadmap for Medical Research, a national project, the National Institute of Health in the USA has already started improving its chemical compound library and initial screening nationwide, conducting the first stage of drug development in public institutes. 

A similar project is ongoing in Japan; however, it is not limited to national projects alone, but strives to advance comprehensive life science research based on cooperation with the international community. This is important for both development of new medicines and for health promotion.

Chemical biology is a basic academic field in which genome information is analyzed using bioactive organic compounds, making possible research into life science and diseases. On the other hand, chemical biology is an academic field in which the results can be directly used for developing medicines and its significance is being recognized rapidly.

In this situation, combinatorial chemistry plays an important role as a means of creating a chemical library.

At this conference, research of combinatorial chemistry and chemical biology will be discussed among the following participants.


Mark Bradley (University of Edinburgh), Takayuki Doi (Tohoku University), Paul R. Hanson (University of Kansas), Oliver Kappe (University Graz), Yoon-Sik Lee (Seoul National University), Morten Meldal (Carlsberg Laboratory), Yasuhiro Uozumi (Institute for Molecular Science), Motonari Uesugi (Kyoto University), Peter H. Seeberger (ETH), Bing Yan (St. Jude Children's Research Hospital)

(Titles are omitted from names. Names are in no particular order)


Pre-registration required.

Registration Quota: 150 attendees

For more information, please go to Japan Combinatorial Chemistry Focus Group

Pre-registration participation fee: (for those who registered by the deadline): JCCF Full members: 25,000 yen for business persons, 20,000 yen for members of public offices and universities, 5,000 yen for students

Non-members: 30,000 yen for businesses, 25,000 yen for members of public offices and universities, 10,000 yen for students,


Participation fee at door:

JCCF Full members: 30,000 yen for business persons, 5,000 yen for members of public offices and universities, 10,000 yen for students

Non-members: 35,000 yen for business persons, 30,000 yen for members of public offices and universities, 15,000 yen for students,


After-seminar party fee: 8,000 yen


Sponsor: Conbinatorial Chemistry & Chemical Biology Organizing Committee

Science Hall, Life Science Center, Suita, Osaka

For more information,


Date: 2009-6-2 (Tue) -

Back to top